Table 1HEDeterministic and probabilistic cost-effectiveness results (per person) for the cost-effectiveness analysis

QALYCost (£)Incremental QALYsIncremental costs (£)ICER (£)
Deterministic
X-ray0.427410083---
MRI0.442099230.0145-160Dominates
Probabilistic
X-ray0.42799886---
MRI0.442297280.0143-158Dominates

ICER = incremental cost-effectiveness ratio; MRI = magnetic resonance imaging; QALY = quality-adjusted life year.

From: 3, Evidence review and recommendations

Cover of Diabetic Foot Problems
Diabetic Foot Problems: Inpatient Management of Diabetic Foot Problems.
NICE Clinical Guidelines, No. 119.
Centre for Clinical Practice at NICE (UK).
Copyright © 2011, National Institute for Health and Clinical Excellence.

All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.